2.50Open2.50Pre Close0 Volume20 Open Interest15.00Strike Price0.00Turnover97.35%IV-2.12%PremiumOct 18, 2024Expiry Date2.76Intrinsic Value100Multiplier20DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.7785Delta0.1077Gamma4.01Leverage Ratio-0.0193Theta-0.0056Rho-3.12Eff Leverage0.0086Vega
Stoke Therapeutics Stock Discussion
In the rapidly evolving world of biotechnology, companies like Stoke Therapeutics are pioneering groundbreaking treatments that could potentially change the lives of patients with severe diseases. The recent buzz surrounding Stoke Therapeutics, particularly their work on an anti-epilepsy drug, STK-001, underscores the transformative potential of RNA-based therapies in addres...
No comment yet